Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
…
continue reading
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
…
continue reading
Join the EMJ GOLD team for a weekly exploration of all things pharma, featuring thought-provoking conversations, insightful interviews with high-profile industry guests and discussions about the latest trends and innovations taking the pharmaceutical sphere by storm. Whether its marketing, medical affairs, the use of digital techniques to create patient-centric approaches or something in between, there's something here for anyone interested in the pharmaceutical industry.
…
continue reading
The Off Script podcast offers in-depth interviews and discussions with industry experts about hot-button topics in pharma, and goes behind the scenes of Pharma Manufacturing’s print and online coverage, which follows the industry’s biggest issues surrounding scale-up, technology innovations, regulations and more
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Discover the transformative power of GenAI, Data Analytics, Social Intelligence, and Physician Influencer Marketing that is shaping the future of pharma marketing. Join us, as we pave the pathway to a novel pharma marketing landscape, bringing to you conversations that meet at the intersection of technology and marketing. Hosted by Saumya Prakash, Co-Founder Multiplier AI Solutions, this podcast is spearheading the dialogues on disruptions in pharma marketing. Know more about us at: https:// ...
…
continue reading
The Future of Pharma with ISPE Boston. Find out where the pharmaceutical industry is headed and what it means for you. Join host Samir Gondalia as he chats with the thought leaders of the pharma world about the new technologies, innovative applications and emerging markets and how it’s going to influence the future of Pharma.
…
continue reading
There are a million and one science podcasts out there but none of them are quite like Dose of Pharma! Made for students, by students, we provide you with bite-sized doses of discussions on all sorts of science content, personal development, student life, and STEM careers. With a nugget of wisdom available for you to take away from each episode, you’ll be glad you decided to embrace your inner nerd and start listening to us!
…
continue reading
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
…
continue reading
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access - Powered by Petauri.
…
continue reading
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership ...
…
continue reading
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
…
continue reading
A podcast that examines how today’s healthcare system affects the doctor-patient relationship and impacts how doctors and patients experience it.
…
continue reading
The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.
…
continue reading
In this series, we’ll be discussing the key topics that Pharma Marketing is seeking to address. What you’ll get… Gaining expertise and experience from experts in the industry. Practical tips to turn theory and concepts in real Pharma scenarios. Tap into a network of other marketers who are going through the same journey.
…
continue reading
On this podcast, you'll find interviews with high-performing successful individuals in Life Sciences. On a weekly basis, we cover their proven methods, principles, strategies, and mindsets to implement new technologies that scale to meet the needs of people in our world.
…
continue reading
Hello Combi-Nation! Our industry fee complicated sometimes. Drugs, devices, clinical trials, submissions, sterilization validation, design control, risk management, market access reimbursement, the list goes on. My name is Subhi Saadeh. I've spent over a decade in medical device, pharma, and combination product development. My goal is mastery, so this podcast is to ask questions I have to people who may have the answers. Whether you're background is Pharma, Device or both, I invite you to li ...
…
continue reading
The Pharmaverse is a leadership podcast that brings you exclusive insights from the stars of the Pharma universe. Hosted by Michael Pietrack, a top Pharma and Biotech recruiter, whose team partners with the most recognizable Pharma companies in the industry, as well as the hottest of the emerging Biotechs. In each episode, Michael sits down with influential and innovative leaders in the Pharmaceutical and related industries. Listeners will hear from stars from all sectors of the Pharmaverse ...
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
pharmaphorum is one of the leading global channels for insight into the pharma and healthcare industry – and is essentially a group of passionate people who like asking excellent questions. Our podcasts offer a chance to pose some of these questions to the keenest minds in our industry to look at the big issues and opportunities facing pharma, biotech and healthcare today. With interviews and contributions from a host of industry experts and insiders, the pharmaphorum podcast is a must-liste ...
…
continue reading
Aleksandra Zuraw from Digital Pathology Place discusses digital pathology from the basic concepts to the newest developments, including image analysis and artificial intelligence. She reviews scientific literature and together with her guests discusses the current industry and research digital pathology trends.
…
continue reading
I'm passionate about helping pharma field teams feel confident using technology to engage with healthcare professionals. I want them to feel good about themselves and achieve amazing results. To explore this topic, I've been interviewing inspiring pharma leaders to learn from them for this Digital Transformation Series. - Mehrnaz Campbell, Founder and CEO of Cheemia & Cheemia ReSET Author of The Omni Advantage
…
continue reading
Welcome to Pro Pharma Talks, where we bring clarity to a variety of healthcare topics -- from pharmacy to medical insurance, and more!
…
continue reading
Welcome to our podcast where we dive into the dynamic world of pharmaceutical careers with a sprinkle of fun and a dash of humor! With nearly a decade of experience in medical affairs, a bioscience master’s degree, and a background in medcomms, I'm here to make your journey into pharma exciting and accessible. Whether you’re thinking about a career change, making the leap from an agency to pharma, or coming from a clinical background or bioscience education, this podcast is for you. From my ...
…
continue reading
Thought leadership for Pharmaceutical and MedTech executives
…
continue reading
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
…
continue reading
Just about me and may everyday life.
…
continue reading
American Healthcare Entrepreneurs and Execs you might want to know. Talking. Relentless Health Value is a weekly interview podcast hosted by Stacey Richter, a healthcare entrepreneur celebrating fifteen years in the business side of healthcare. This show is for leaders in pharma, devices, payers, providers, patient advocacy and healthcare business. It's for health industry innovators, entrepreneurs or wantrepreneurs or intrapreneurs. Relentless Healthcare Value is the show for you if you wan ...
…
continue reading
The Pharma Letter Podcast provides in-depth discussion and analysis focused on key trends, companies and events in the pharmaceutical and biotech industries. Our guests come from a broad array of sectors and business functions, from early stage research in biopharmaceuticals, to patient engagement and marketing, supply chain management and life sciences investing. Podcasts are typically 20-30 minutes in length and are released approximately once every two weeks.
…
continue reading
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves. Brought to you by Singular: Building Brilliant Biotechs. Connect with us at: LinkedIn: https://www.linkedin.com/company/singular-biotech/ www.singular-biotech.com
…
continue reading
Just a spoonful of humor helps the medicine go down. Inspired by his brother’s suicide and her hellacious experience with prescription meds, bi-coastal best friends David and Karen unleash their outlandish banter on their shared passion for mental health. They challenge the over-medicated status quo, asking questions and exploring new holistic alternatives with their guests from a wide array of experience and discipline.
…
continue reading
Welcome to The Pharma Podcast - Insights from industry experts and business leaders about important and current topics in Canadian Pharma, Biotech and Medtech.
…
continue reading
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues ...
…
continue reading
Its a weekly podcast, Get All latest Pharmaceutical GMP updates, FDA warning letters, Guidelines etc...
…
continue reading
The audio companion to Bloomberg Opinion’s beloved Money Stuff column hosted by its author Matt Levine, “whose deadpan style mixes technical elucidation and wit” (NY Times). Once a week, Matt and his friend, Bloomberg News reporter and TV host Katie Greifeld, talk about Wall Street, finance and…other stuff. New episodes every Friday.
…
continue reading
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
…
continue reading
This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.
…
continue reading
Welcome to 'Controversial as Fuck' with Hollie Wild, where thought leaders and industry changers converge to amplify voices often silenced and tackle the taboo. Each episode delves into the tough discussions surrounding big pharma, mainstream media, social justice movements, and beyond, grilling the sacred cows of our time. This isn't just a podcast—it's a revolution for those who dare to think differently, engage in conversations that drive real change, and inspire resilience across mental, ...
…
continue reading
Discussing the tragic death of nipsey as well as big pharma...
…
continue reading
Welcome to the TKG PACT Executive Briefing, where in 3-minutes we highlight healthcare’s critical market access issues, policies, challenges, or trends. This resource offers condensed, 3-minute episodes of market insights. Our passion is on achieving the Quintuple Aim of enhancing patient experience, improving population health, reducing costs, improving the work life of health care providers and staff., and enhancing health equity in all aspects of care delivery. I’m Dr. Warren Smedley, tha ...
…
continue reading
Pharma Flex RX is newly launches joint pain solution its work for all ages people, try it now. https://installmentloanerx.org/pharma-flex-rx/
…
continue reading
The Tucker Carlson Show is your beacon of free speech and honest reporting in a media landscape dominated by misinformation. The only solution to ending the propaganda spiral is by telling the truth. That's our job. Every day. No matter what.
…
continue reading
Facebook: https://www.facebook.com/pharmaCR/ Soundcloud: https://soundcloud.com/user-890679010 Twitter: @Pharma_CR Mailing List: eepurl.com/cWZLrP Email: pharmacrpodcast@gmail.com
…
continue reading
Podcast series featuring interviews with industry experts and thought leaders on topics related to Commercial Excellence in Pharma. For more information about Valeocon, visit www.valeocon.com.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
Living with cystic fibrosis: the challenges and triumphs along the way. Live-Breathe-Inspire
…
continue reading
Each week the MPR team brings you the top stories from the world of medicine and pharma in a matter of minutes. With 35 years of publishing drug information behind us, you can rely on MPR to provide accurate and up-to-date news.
…
continue reading
Healthcare: it’s a giant industry with a noble cause—supporting human health. But here in America, it’s expensive and unwieldy, and has inspired decades of (mostly) failed reform attempts. How did we get here? And can we do better? Welcome to Insight Unpacked, where we delve into complex business topics and emerge with insights from Kellogg School faculty. For our second season, we untangle the often-competing incentives that motivate the major players in the system, from hospital networks a ...
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Revolutionizing HCP Engagement: The Power of AI-Driven Solutions in Pharma
36:31
36:31
Play later
Play later
Lists
Like
Liked
36:31
Unlock the power of AI in pharma marketing with our latest episode featuring industry veteran Amaninder Singh Dhillon. From his journey as a trainee to a franchise lead at AstraZeneca, Dhillon shares invaluable insights on leveraging AI for personalized HCP engagement. In this episode, we explore: How data digitization forms the backbone of AI-driv…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Beyond the Counter: Locummate with Kavita Nadan
43:06
43:06
Play later
Play later
Lists
Like
Liked
43:06
The pharmacy field has traditionally been associated with dispensing medications and providing essential healthcare advice to patients. However, as the healthcare landscape evolves, so does the pharmacist's role. Today, the intersection of pharmacy and entrepreneurship presents an exciting frontier that allows pharmacists to leverage their expertis…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry News
2:49
2:49
Play later
Play later
Lists
Like
Liked
2:49
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Leqembi, a new biotech drug, has been approved in the UK, but reimbursement may not follow due to concerns about the cost to the NHS. The FDA defended its med device chief's tenure after ethics concerns were raised. Employe…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
E127 | Who is using your face? Find out with AI
26:56
26:56
Play later
Play later
Lists
Like
Liked
26:56
In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by IdentifAI founders Justin Marciano and Paul Vann to explore the deep fake challenge and the innovative solutions they are developing. The pair share their unique backgrounds and motivations for founding the company, emphasising the critical need to address the growing threat of …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FDA approves Ascendis drug, Lykos PTSD treatment rejected, Novartis bid blocked [The good, the bad, the ugly]
3:21
3:21
Play later
Play later
Lists
Like
Liked
3:21
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week: The good — FDA approves Ascendis hypoparathyroidism drug The bad — FDA rejects Lykos MDMA PTSD drug The ugly — Judge blocks Novartis bid to stop generic blockbuster heart drug…
…
continue reading
![Artwork](/static/images/128pixel.png)
51
Calley & Casey Means: The Truth About Ozempic, the Pill, and How Big Pharma Keeps You Sick
2:33:31
2:33:31
Play later
Play later
Lists
Like
Liked
2:33:31
Whistleblowers Calley and Casey Means expose how Big Pharma co-opted government agencies and the food industry to poison America and keep us sick. Buy Casey and Calley’s book, “Good Energy” here - https://www.caseymeans.com/goodenergy (00:00) Art of the Surge (00:54) Who Are Casey and Calley Means? (10:16) Seed Oils and the Lies of the Food Pyramid…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Achieving Work-Life Integration in Med Affairs with Jen Mohawk
29:00
29:00
Play later
Play later
Lists
Like
Liked
29:00
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics. They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires. Jen shares her journey from academia to the b…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
S07 E10: Astellas’ Tadaaki Taniguchi on how to challenge the status quo
28:43
28:43
Play later
Play later
Lists
Like
Liked
28:43
In this season finale of the EMJ GOLD podcast, Isabel speaks to Dr Tadaaki Taniguchi, Chief Medical Officer, Head of Medical and Development, Astellas Pharma, about how he strives to challenge the status quo in the pharmaceutical industry. The two discuss how Tadaaki’s time as a surgical oncologist has influenced his leadership style, how collabora…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Engage NHS healthcare decision-makers with RWD
20:55
20:55
Play later
Play later
Lists
Like
Liked
20:55
Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted par…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
AI Revolution: Transforming Biopharma with Andree Bates
51:28
51:28
Play later
Play later
Lists
Like
Liked
51:28
Summary Dr. Andrée Bates, a pioneering force in the realm of artificial intelligence within the pharmaceutical industry, shares insights on the evolving role of AI in pharma, the future of healthcare innovation, and her advocacy for women in leadership. She discusses the early days of AI in pharma, the challenges faced, and the evolution of AI term…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
How Expert Pharma Marketers Navigate Privacy
1:26
1:26
Play later
Play later
Lists
Like
Liked
1:26
In today's consumer landscape, privacy concerns reign supreme. Pharmaceutical and medical device manufacturers must prioritize meeting the expectations of this privacy-conscious generation. This begins with three key measures: 1. Consent Management: Clear communication about data usage is essential, aligning with regulations like CCPA and GDPR. See…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Episode 24 - Dr. Samuel Ewing and the New World of Digital Hospitals
36:42
36:42
Play later
Play later
Lists
Like
Liked
36:42
My guest in this episode is Dr. Samuel Ewing. He is the Global Head of Pharmaceutical Partnerships at Doccla. Before joining Doccla, Dr. Ewing led the development of a connected auto-injector system for Roche’s Alzheimer’s disease program at Capgemini Engineering. He also led the development of Biofourmis’s wearable vital sign monitoring platform. …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Logistics & Leadership in Life Sciences: A Chat with Artug Acar
26:42
26:42
Play later
Play later
Lists
Like
Liked
26:42
In this episode of Life Science Success, host Don interviews Artug Akar, Chief Operating Officer at Mercury, about his journey from mechanical engineering in Turkey to leading logistics transformation in the life sciences and healthcare sectors. Artug shares insights on the complexities and challenges of logistics, particularly cold chain managemen…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Insights on Biopharma Success and Innovation - Tim Glennon
44:05
44:05
Play later
Play later
Lists
Like
Liked
44:05
Scaling Innovations in Life Sciences: An Interview with Tim Glennon | Life Science Success In this episode of Life Science Success, host Don interviews Tim Glennon, the principal owner of Illumination Strategy Group. With more than 26 years of experience in the pharmaceutical industry, Tim shares his journey, starting from his early career at Bayer…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
MPR Weekly Dose Podcast #215 — HIV Drug Discontinuation; Combo for EGFR-Mutated NSCLC; Update on Unapproved Potassium Phosphates in Peds; Otezla Indication Expanded; Tirzepatide Diabetes Risk Reduction ...
12:38
12:38
Play later
Play later
Lists
Like
Liked
12:38
Genentech decide to remove Fuzeon from US market; Rybrevant and Lazcluze approved as first-line treatment for certain patients with EGFR-mutated advanced NSCLC; FDA warning regarding unapproved potassium phosphates; Otezla approval expanded to include treatment of pediatric patients; Results from tirzepatide diabetes risk reduction study.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
What Chevron’s overturn means for biopharma
25:15
25:15
Play later
Play later
Lists
Like
Liked
25:15
For the last 40 years, when federal legislation was ambiguous or left an administrative gap, courts were required to defer to the interpretation of agencies. This stipulation, called the Chevron deference, gave agencies room to advance their regulatory priorities. The Supreme Court overturned the doctrine in June, bringing significant implications …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
100: AI in Pathology: DigiPath Digest #9 (From Retinal Assessment to Tumor Prognostics)
43:12
43:12
Play later
Play later
Lists
Like
Liked
43:12
Send us a Text Message. In this episode, we celebrate the 100th edition of the Digital Pathology Podcast! Thank you so much for being part of this journey! You are my Digital Pathology Trailblazers and I prepared a Digital Pathology Trailblazer manifesto for us! This is the 9th edition of DigiPath Digest, and we are attracting more and more people …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Tucker Carlson Reacts to Kamala Harris’s DNC Speech (with Special Guest Jason Whitlock)
54:26
54:26
Play later
Play later
Lists
Like
Liked
54:26
While Kamala Harris takes center stage at the DNC, Tucker Carlson and Jason Whitlock are providing unfiltered analysis in real-time. Based on the media’s portrayal of this new nominee, you’d never know that she’s been the 21st century’s least popular vice president and that her own party’s voters rejected her in 2020. You’d think she was a cultural…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
15:22
15:22
Play later
Play later
Lists
Like
Liked
15:22
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health disorders. Content warning: This episode does contain mentions of sexual assault and abuse.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcas…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
12. Xanax, IBS, Reiki & Journal Speak: How Life As A Highly Sensitive Person Can Make You A Jedi
1:38:34
1:38:34
Play later
Play later
Lists
Like
Liked
1:38:34
We now welcome to "A Better Pill," Amy Eidelman. She has struggled her entire life with food and environmental allergies. In her early 20s, her sensitivities devolved into full-blown IBS, leading her into Xanax dependency and recovery, and more recently several bouts of long Covid. You’d be hard-pressed to find a more sensitive body than hers. Yet …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Encore! EP413: The Intersection of Healthcare Waste, Value-Based Care, and the Potential Rising Power of PCPs, With Will Shrank, MD
34:41
34:41
Play later
Play later
Lists
Like
Liked
34:41
My conversation today is with Will Shrank, MD. Dr. Shrank led the evaluation group at CMMI (Center for Medicare and Medicaid Innovation). He has spent time in the private sector, first at CVS Health and UPMC (University of Pittsburgh Medical Center) as chief medical officer of the health plan in Pittsburgh, and then as the chief medical officer for…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: August 21, 2024 - Leadership Changes, FDA Setbacks, and Industry Updates
1:58
1:58
Play later
Play later
Lists
Like
Liked
1:58
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Biopharma news on August 21, 2024 saw changes in Biomarin's C-suite, with Greg Friberg and James Sabry taking over R&D and business development. BridgeBio launched GondolaBio for rare disease drug programs, while Regener…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bethany Hamilton: Men in Women’s Sports, Marriage Advice, and Why You Need to Homeschool Your Kids
2:01:52
2:01:52
Play later
Play later
Lists
Like
Liked
2:01:52
Bethany Hamilton, who is famous for surviving a shark attack while surfing as a teenager, discusses homeschooling her kids and tips for a happy marriage. (00:00) How to Deal with Fear (16:01) Motherhood (26:22) Homeschooling (39:09) Leadership and Marriage (1:35:26) Christianity (1:41:47) Opposing Men in Women’s Sports Paid partnerships with: Bass …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 20 | 🍿Comment Chaos: Stirring the Pot in the Digital Age
24:59
24:59
Play later
Play later
Lists
Like
Liked
24:59
In this unapologetic episode of "Comment Chaos," I take on the madness of TikTok censorship, the audacity of social media trolls, and the polarizing debates that light up the internet. From the absurdity of follower counts to the deep-rooted issues of self-authority, this episode is a no-holds-barred exploration of the digital battleground. Tune in…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
The Realities of Corporate Life in Biopharma: What You Need to Know!
19:18
19:18
Play later
Play later
Lists
Like
Liked
19:18
Send us a Text Message. In this episode of The Agency Advantage, I delve into what it's truly like to work in a corporate environment, specifically within a large biopharma company. Aimed at professionals looking to pivot from academia, smaller companies, or other sectors like medical practice or pharmacy, the discussion highlights the complexities…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
150 - Ocular/Ophthalmic Drug Delivery, Intravitreal Administration, Glaucoma, WetAMD, Vision, Range and Presence with Maysaa Attar
38:58
38:58
Play later
Play later
Lists
Like
Liked
38:58
On this episode, I was joined by Maysaa Attar, Senior Vice President of R&D at Bausch + Lomb. On this episode, Maysaa discusses:00:00 Welcome to Episode 150!03:00 Challenges and Innovations in Ocular Drug Delivery09:30 Understanding Intravitreal Injections13:26 Regulatory Considerations for Ocular Products20:48 Innovations in Glaucoma Treatment29:1…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
FNIH Study Shows Promise of Blood Tests for Alzheimer’s Disease, featuring Dementia Expert Dr. Schindler and FNIH Neuroscience Director Dr. Travaglia
36:43
36:43
Play later
Play later
Lists
Like
Liked
36:43
In this episode, Ayesha spoke with Alessio Travaglia, PhD, neuroscientist and Director Neuroscience at the Foundation for the National Institutes of Health (FNIH) and Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University. Results from a head-to-head study led by the FNIH Biomarkers Consortium, with data analysis led …
…
continue reading
This week on Careers in Discovery, we're delighted to be joined by Kenny Duncan, SVP of Chemistry at Accent Therapeutics, where we explore the evolving landscape of drug discovery and the critical role chemistry plays in advancing new therapies. Kenny takes us through his incredible career journey, from his early passion for chemistry to becoming a…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates
2:26
2:26
Play later
Play later
Lists
Like
Liked
2:26
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.J&J has acquired heart failure implant maker V-Wave for up to $1.7 billion, while Medtronic reiterates its unchanged diabetes strategy despite a partnership with Abbott. Histosonics secured $102 million for a noninvasive …
…
continue reading
Subscriber-only episode We dive into the critical issue of racial bias in AI, highlighted by a recent Yale study focusing on ChatGPT. This has significant implications for clinical research sponsors, sites, and principal investigators. We also explore the FDA's perspective on AI in clinical trials, presented by Dr. Elzarrad. Overview of the Yale St…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Structuring the unstructured: Deterministic AI and white box data cleanliness
18:31
18:31
Play later
Play later
Lists
Like
Liked
18:31
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Jane Reed, director of life sciences at Linguamatics, an IQVIA company, to discuss some of the major barriers preventing researchers from accessing the data they need to advance drug discovery and development and address safety concerns – and just how AI technologies can assist.…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Provider Insights on the Impact of 340B Pricing
3:54
3:54
Play later
Play later
Lists
Like
Liked
3:54
Send us a Text Message. Provider Insights on the Impact of 340B Pricing. We frequently get asked for insights on how the 340B Drug Pricing Program may... or may not... be impacting the prescribing choices of participating covered entities. The Health Resources and Services Administration (HRSA) administers this federal program which is intended to …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Evolving landscape of personalized Pharma Marketing with Dr. Kavita Lamror
27:58
27:58
Play later
Play later
Lists
Like
Liked
27:58
Explore the dynamic shift from traditional to digital marketing strategies in the pharmaceutical sector that is being triggered and drive by GenAI. Join us for a fascinating conversation with Dr. Kavita Lamror, a leading expert in real-world evidence and digital transformation at Maxis Clinical Sciences. In this episode, Dr. Kavita delves into how …
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Your Essential Guide to Industry Updates
2:30
2:30
Play later
Play later
Lists
Like
Liked
2:30
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.On August 19, 2024, the FDA approved the first at-home syphilis test by NowDiagnostics, providing quick results with just a drop of blood. Dupont acquired Donatelle Plastics for $313 million, while Boston Scientific resub…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Vince Coglianese: DNC Predictions, Don Lemon, and Why Kamala Harris Is Terrified
2:56:08
2:56:08
Play later
Play later
Lists
Like
Liked
2:56:08
By Tucker Carlson Network
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Ep. 19 | Trauma, Psychedelics, the Patriarchy, Controlled Opposition and Jesus: Uncut with Holly Loxton
1:30:20
1:30:20
Play later
Play later
Lists
Like
Liked
1:30:20
Dive into an unfiltered conversation with powerhouse Holly Loxton as we explore trauma, healing, and the transformative power of psychedelics. We'll challenge the concept of the patriarchy and dissect its impact on our lives. Prepare for thought-provoking discussions on politics, religion, and the New Age movement, all with a focus on questioning e…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
41:14
41:14
Play later
Play later
Lists
Like
Liked
41:14
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develop treatments for inflammatory bowel disease (IBD).By Citeline
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Steering Through Setbacks with AVEO Oncology's Michael Bailey
58:06
58:06
Play later
Play later
Lists
Like
Liked
58:06
We love to hear from our listeners. Send us a message. For all the drug commercialization successes he's played a leading hand in during his tenures at GSK, Genentech, and ImClone—Androderm, Augmentin, necitumumab, and Erbitux among them—Michael Bailey concedes that he's likely better known for his failures. After hearing his stories on this episod…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: Cutting through the noise in the world of healthcare.
2:33
2:33
Play later
Play later
Lists
Like
Liked
2:33
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Medicare has revealed the results of drug price negotiations, showing $6 billion in savings for taxpayers from talks involving drugs like Eliquis and Xarelto. Lilly has opened an R&D hub in Boston, while Ovid and Lexicon ar…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Scrip's Five Must-Know Things - 19 August 2024
15:10
15:10
Play later
Play later
Lists
Like
Liked
15:10
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezdiffra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.https://scrip.citeline.com/SC1507…
…
continue reading
Today we're diving into a critical issue that has shaken the pharmacy world. Recently, a pharmacy owner was sentenced for paying illegal kickbacks and engaging in a money laundering conspiracy. This case has significant implications for promotional compliance within the pharmacy industry, and we're here to explore them in detail. In a landmark case…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
35:44
35:44
Play later
Play later
Lists
Like
Liked
35:44
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.More On These Topics From The Pink SheetMedicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear: https://pink.citeline.com/PS155128/Medicare-Negoti…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Hurt People Hurt People: SBUX, LMEs, BofA
29:56
29:56
Play later
Play later
Lists
Like
Liked
29:56
A between-vacations episode in which Katie and Matt discuss Starbucks's new CEO, the capital solutions business, banking hours and being a horse. See omnystudio.com/listener for privacy information.By Bloomberg
…
continue reading
![Artwork](/static/images/128pixel.png)
1
MPR Weekly Dose Podcast #214 — Livdelzi Approved for PBC; Novel Prurigo Nodularis Tx; FDA Denies MDMA Therapy; Yorvipath Approved; Digital Therapy for MDD
14:19
14:19
Play later
Play later
Lists
Like
Liked
14:19
New Treatment for Primary Biliary Cholangitis; Nemluvio approved for prurigo nodularis; FDA Denies MDMA for PTSD; New hypoparathyroidism treatment; First digital therapeutic approved for depression.
…
continue reading
The TROP2 antibody-drug conjugate race has heated up among three Big Pharma companies: Gilead Sciences, AstraZeneca and Merck. Fierce Pharma’s Angus Liu recently took a deep dive into the three TROP2 front-runners. In a feature article, he examined the strengths and potential challenges facing each candidate, as well as the considerations behind th…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Pharma and Biotech Daily: The Latest in Gene Therapy, Drug Pricing, and Cancer Research
4:24
4:24
Play later
Play later
Lists
Like
Liked
4:24
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Evotec is exiting the gene therapy field and cutting jobs due to a slowdown in research spending. Merck has made a $700 million bet on an antibody drug for immune diseases, while Lilly has opened a new R&D hub in Boston. Ov…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
BIO Bites: Making Global Connections and Collaborations at BIO 2024 (Part 3)
48:15
48:15
Play later
Play later
Lists
Like
Liked
48:15
Back in June, MTPConnect led the Australian delegation at BIO 2024 in San Diego organising a range of activities to showcase Australia’s innovative life sciences sector to the international biotech industry. With a powerful #TeamAustralia focus and a 500-strong delegation from Australia, BIO2024 was the biggest and best ever! In this BIO Bites epis…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Rob Schneider: SNL Glory Days, Losing Friends Over Politics, and His Response to Daughter Elle King
2:26:39
2:26:39
Play later
Play later
Lists
Like
Liked
2:26:39
Rob Schneider is a comedian, actor, and Emmy-nominated SNL writer who authored the upcoming book, You Can Do It!: Speak Your Mind, America, an unfiltered and outrageously funny commentary on the threats to free speech in America. Pre-order now wherever books are sold. https://bit.ly/YouCanDoItBook (00:00) Tour Dates (00:45) Rob Schneider Responds t…
…
continue reading
![Artwork](/static/images/128pixel.png)
1
Encore! EP402: What Physicians Trying to Clinically Integrate Care in the Real World Need to Know, With Amy Scanlan, MD
32:50
32:50
Play later
Play later
Lists
Like
Liked
32:50
This encore episode is with Amy Scanlan, MD. It was, in fact, one of our most popular episodes of the past year. It is still just as relevant today in a slightly different way. It’s interesting how things which were said maybe a year ago have shades of meaning which become evident as time goes on. So, I liked this show a lot in the second listen wi…
…
continue reading